Title Relaxin and erythropoietin significantly reduce uterine tissue damage during experimental ischemia–reperfusion injury /
Authors Jakubauskienė, Lina ; Jakubauskas, Matas ; Ražanskienė, Gintarė ; Leber, Bettina ; Weber, Jennifer ; Rohrhofer, Lisa ; Ramašauskaitė, Diana ; Strupas, Kęstutis ; Stiegler, Philipp ; Schemmer, Peter
DOI 10.3390/ijms23137120
Full Text Download
Is Part of International journal of molecular sciences.. Basel : MDPI. 2022, vol. 23, iss. 13, art. no. 7120, p. [1-11].. eISSN 1422-0067
Keywords [eng] transplantation ; uterus ; ischemia–reperfusion injury ; relaxin ; erythropoietin
Abstract [eng] Successful uterus transplantation, a potential treatment method for women suffering from absolute uterine infertility, is negatively affected by ischemia–reperfusion injury (IRI). The aim of this study is to investigate the protective effect of relaxin (RLX) or/and erythropoietin (EPO) on experimental uterus IRI. Eighty rats, randomly assigned into eight groups (n = 10/group), were pretreated with either saline, 5 μg/kg human relaxin-2, 4000 IU/kg recombinant human erythropoietin or their combination. Ischemia was achieved by clamping the aorta and ovarian arteries for 60 min, following 120 min of reperfusion and tissue sampling. For sham animals, clamping was omitted during surgery. There were no differences in tissue histological score, malondialdehyde (MDA) and superoxide dismutase (SOD) levels, myeloperoxidase (MPO) and TUNEL-positive cell count between all sham-operated rats. Pretreatment with RLX preserved normal tissue morphology, reduced MDA levels, MPO and TUNEL-positive cell count, preserved SOD activity and upregulated NICD and HES1 gene expression when compared to the control group. Pretreatment with EPO reduced MDA levels. In conclusion, pretreatment with RLX, EPO or a combination of both EPO and RLX significantly alleviates uterine tissue damage caused by IRI.
Published Basel : MDPI
Type Journal article
Language English
Publication date 2022
CC license CC license description